来宝网Logo

热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

现在位置首页>技术资料首页>行业动态>公司动态>金佰利计划剥离医疗保健业务并上市

金佰利计划剥离医疗保健业务并上市

Kimberly-Clark2013年11月19日 9:47 点击:2181

   

2013年11月14日  全球健康卫生护理领域巨头金佰利公司(Kimberly-Clark)表示,它将寻求剥离健康护理业务。为了维持股票价格而砍掉公司业务,金佰利是最新一家这么做的公司。


即将被剥离的健康护理部门专注于售卖手术和防感染产品以及止痛治疗、呼吸和消化道相关的医疗设备。去年这个部门的销售额是16亿美元,只占金佰利211亿美元营收的一小部分。

金佰利董事会主席兼首席执行官托马斯•福克(Thomas J. Falk)在一份声明中表示,自上世纪70年代起健康护理部门就是公司的一部分。这个部门的战略协调性和增长优先度随着时间推移已经发生改变。

公司认为现在将其剥离对于股东来说是有益的。一旦公司董事会同意,健康护理部门可能会在2014年第三季度公开上市。为金佰利提供咨询的是投资银行摩根士丹利(Morgan Stanley)。
 

November 14, 2013

Kimberly-Clark Pursuing Spin-Off Of Health Care Business

Spin-Off to K-C Shareholders Would Create Health Care Company with Approximately $1.6 Billion in Annual Net Sales and Leading Market Positions
Move Would Further Sharpen K-C's Focus on Its Consumer and K-C Professional Brands

 

 

DALLAS, Nov. 14, 2013 /PRNewswire/ -- Kimberly-Clark Corporation (NYSE: KMB) today announced that its board of directors has authorized management to pursue a potential tax-free spin-off of the company's health care business.  A spin-off would create a stand-alone, publicly traded health care company with approximately $1.6 billion in annual net sales and leading market positions in both surgical and infection prevention products and medical devices. 

Chairman and Chief Executive Officer  Thomas J. Falk said, "While K-C Health Care has been part of our company since the 1970's, its strategic fit and growth priorities have changed over time and we now think that pursuing a spin-off makes sense for our shareholders.  This move would allow K-C Health Care to optimize its performance and flexibility to pursue its own value-creation opportunities.  A spin-off would also allow us to further sharpen our focus on our consumer and K-C Professional brands.  This announcement is further evidence of our focus on creating shareholder value and how we use portfolio management to run our company."   

Robert E. Abernathy, currently Kimberly-Clark Group President — Europe, Global Nonwovens, and Continuous Improvement and Sustainability, will become chief executive officer of the new health care company if the spin-off ultimately occurs.  Abernathy joined Kimberly-Clark in 1982 and has held senior management positions throughout the company, including having overall responsibility for K-C Health Care from 1997 to early 2004.   Joanne B. Bauer will continue as Kimberly-Clark President — Global Health Care, work closely with  Robert Abernathy on separation planning and retire when the spin-off is completed.

"Robert is a seasoned executive with a long track record of success and I'm confident he will be a terrific leader of the new company," said Falk.  "He is excited about working with the many talented individuals on the health care team to create shareholder value as a stand-alone company."

Potential Transaction Details

Company management will continue to analyze a potential spin-off and expects to make a final recommendation to the board of directors in the next several months.  If the board approves a spin-off, a transaction would likely be completed by the end of the third quarter of 2014, subject to market, regulatory and other conditions.  The company expects that the spin-off would be in the form of a tax-free distribution of 100 percent of the new company's common stock to Kimberly-Clark shareholders.  Morgan Stanley has been retained to assist Kimberly-Clark in the pursuit of the spin-off.

Information about K-C Health Care

K-C Health Care sells surgical and infection prevention products for the operating room and a portfolio of innovative medical devices focused on pain management, respiratory and digestive health.  The business has the number one or number two market position in several product categories in the United States, including sterilization wrap, face masks, surgical drapes and gowns, closed suction catheters, pain pumps and enteral feeding tubes.  K-C Health Care is a global leader in education to prevent healthcare-associated infections.  Products are sold primarily under the Kimberly-Clark and ON-Q brand names.

K-C Health Care net sales in 2012 were $1.6 billion, with about 70 percent in North America and most of the rest in Europe and Asia.  Total net sales are split approximately 70 percent surgical and infection prevention products and 30 percent medical devices.  The business had more than 16,000 employees at the end of 2012, with a large majority located in low-cost manufacturing operations in Latin America and Asia.  Business unit headquarters are in Roswell, Georgia.

More information on K-C Health Care is available at www.kchealthcare.com.

Conference Call

A conference call to discuss this news release will be held on November 15, 2013 at 9 a.m. (CST).  The conference call will be simultaneously broadcast over the World Wide Web.  Stockholders and others are invited to listen to the live broadcast or a playback, which can be accessed by following the instructions set out in the Investors section of the company's Web site (www.kimberly-clark.com).

About Kimberly-Clark

Kimberly-Clark and its well-known global brands are an indispensable part of life for people in more than 175 countries.  Every day, nearly a quarter of the world's population trust K-C brands and the solutions they provide to enhance their health, hygiene and well-being.  With brands such as Kleenex, Scott, Huggies, Pull-Ups, Kotex and Depend, Kimberly-Clark holds No. 1 or No. 2 share positions in more than 80 countries.  To keep up with the latest K-C news and to learn more about the company's 141-year history of innovation, visit www.kimberly-clark.com.

Certain matters contained in this news release concerning the potential spin-off of the health care business, the anticipated timing of the spin-off, the tax-free treatment of the transaction, the anticipated management of the business to be spun-off, the anticipated net sales and market positions, and the outlook for the health care business as a separate business constitute forward-looking statements and are based upon management's expectations and beliefs concerning future events.  There can be no assurance that the proposed transaction or these future events will occur as anticipated, if at all, or that actual results will be as expected.  Forward-looking statements speak only as of the date they were made, and we undertake no obligation to publicly update them.  For a description of certain factors, such as anticipated currency rates and exchange risks, cost savings and reductions, raw material, energy and  other input costs, and market demand and economic conditions, that could delay or negatively impact the proposed transaction or the health care business, see Item 1A of the company's Annual Report on Form 10-K for the year ended December 31, 2012entitled "Risk Factors.

(Logo: http://photos.prnewswire.com/prnh/20110928/DA76879LOGO)

[KMB:F]

Contact:
Bob Brand
972.281.5335
bob.brand@kcc.com

SOURCE Kimberly-Clark Corporation

(来源: Kimberly-Clark )


全年征稿 / 资讯合作

联系邮箱:kefu@labbase.net

版权与免责声明

  • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, //www.next-search.com,违反者本网将追究相关法律责任。
  • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
  • 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联系,否则视为放弃相关权利。